您要查找的是不是：
- mesenteric vascular resistance 肠系膜血管阻力
- However,Bromocriptine did not alter systemic vascular resistance. 氟呱啶醇能阻断溴隐亭这一作用；
- There was a tendency for the pulmonary vascular resistance to decrease in HS and HSD groups as compared with NS group. 与NS组比较,HS组和HSD治疗后肺血管阻力呈下降趋势。
- Arteriolar relaxation reduces systemic vascular resistance and arterial pressure(afterload). 心脏指数可增加、降低或不变。
- Significantly increase in coronary blood flow due to reduction of vascular resistance. 可增加冠状动脉流量，因为丹参能减低血管阻力。
- Misdiagnosis of mesenteric vascular occlusion 肠系膜血管闭塞症的误诊分析
- acute mesenteric vascular insufficiency 急性肠系膜血管机能不全
- Mesenteric Vascular Occulusion/diag 肠系膜血管闭塞／诊断
- There was no difference of other parameters [cerebral vascular resistance (CVR), compliance, Co and CP] in every group (P>0.05). 其他各项参数(脑血管阻力、顺应性、零压顺应性、临界压力)各组间无差异(P>0．05)。
- Mesenteric vascular occlusion/therapy 肠系膜血管闭影治疗
- Aortic-superior mesenteric vascular bypass 主动脉-肠系膜上动脉血管搭桥术
- Results and Conclusion: Inhaled iloprost can reduce pulmonary vascular resistance and delay the development of primary pulmonary hypertension. 结果和结伦：吸入性伊洛前列素治疗可以降低肺血管阻力和延缓原发性肺动脉高压的进程。
- Mesenteric vascular insufficiency 肠系膜血管供血不足
- Acute mesenteric vascular occlusion 急性肠系膜血管闭塞
- Diltiazem is a benzothiazepine derivative calcium antagonist，which produces antihypertensive effect primarily by relaxation of vascular resistance. 地尔硫卓是一种苯噻氮卓类钙拮抗剂，作用于血管平滑肌使外周血管扩张，心脏后负荷降低，发挥降压作用。
- Mesenteric Vascular Occlusion/surg 肠系膜血管闭塞／外科学
- With prazosin, the average cardiac index increased (by) 20 percent and systemic vascular resistance decreased (by) 20 percent. 使用哌唑嗪，平均心脏指数增加20%25，全身血管阻力下降20%25。
- Conclusion: Epidural anesthesia increase umbilical blood flow，but does not change the umbilical vascular resistance, which is benefical for foetus. 结论： 硬膜外阻滞后可增加脐血流而不增加脐血管阻力，对胎儿血供是有利的。
- Results and Conclusion:Inhaled iloprost can reduce pulmonary vascular resistance and delay the development of primary pulmonary hypertension. 结果和结论:吸入性伊洛前列素治疗可以降低肺血管阻力和延缓原发性肺动脉高压的进程。
- Introduction: Reperfusion syndrome in liver transplant patients is characterized by labile systemic vascular resistance (SVR) and cardiac output (CO). 简介： 肝移植患者发生再灌注综合征的特征是体循环阻力（SVR）不稳定和心输出量（CO）不稳定。
